Oxford Immunotec acquires Imugen for $22.2m cash

27-06-2016

Oxford Immunotec acquires Imugen for $22.2m cash

Svetlana Lukienko / Shutterstock.com

UK-based diagnostics company Oxford Immunotec has announced that it will acquire Imugen, a US clinical laboratory, for $22.2 million in cash.


Oxford Immunotec, Imugen, tick-borne disease, immune system, mergers and acquisitions

LSIPR